These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32573853)

  • 1. Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter Hyperintensities.
    Ramirez J; Dilliott AA; Binns MA; Breen DP; Evans EC; Beaton D; McLaughlin PM; Kwan D; Holmes MF; Ozzoude M; Scott CJM; Strother SC; Symons S; Swartz RH; Grimes D; Jog M; Masellis M; Black SE; Joutel A; Marras C; Rogaeva E; Hegele RA; Lang AE;
    Mov Disord; 2020 Nov; 35(11):2090-2095. PubMed ID: 32573853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
    Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of Brain Parenchymal Damage Related to Cerebral Small Vessel Disease in Carriers of Rare
    Liu ZY; Zhai FF; Liu JY; Zhou YJ; Shu MJ; Huang XH; Han F; Li ML; Zhou LX; Ni J; Yao M; Zhang SY; Cui LY; Jin ZY; Zhu YC
    Neurology; 2023 Nov; 101(20):e1979-e1991. PubMed ID: 37775315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease.
    Huang X; Wen MC; Ng SY; Hartono S; Chia NS; Choi X; Tay KY; Au WL; Chan LL; Tan EK; Tan LC
    Eur J Neurol; 2020 Jun; 27(6):959-966. PubMed ID: 32124496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis.
    Butt A; Kamtchum-Tatuene J; Khan K; Shuaib A; Jickling GC; Miyasaki JM; Smith EE; Camicioli R
    J Neurol Sci; 2021 Jul; 426():117481. PubMed ID: 33975191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort.
    Hanning U; Teuber A; Lang E; Trenkwalder C; Mollenhauer B; Minnerup H
    Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare
    Liu JY; Yao M; Dai Y; Han F; Zhai FF; Zhang DD; Zhou LX; Ni J; Zhang SY; Cui LY; Zhu YC
    Stroke; 2021 Dec; 52(12):3918-3925. PubMed ID: 34404235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine-Altering
    Hack RJ; Rutten JW; Person TN; Li J; Khan A; Griessenauer CJ; ; Abedi V; Lesnik Oberstein SAJ; Zand R
    Stroke; 2020 Dec; 51(12):3562-3569. PubMed ID: 33161844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease.
    Ham JH; Lee JJ; Sunwoo MK; Hong JY; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2016 Mar; 24():95-9. PubMed ID: 26776568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare neurovascular genetic and imaging markers across neurodegenerative diseases.
    Dilliott AA; Berberian SA; Sunderland KM; Binns MA; Zimmer J; Ozzoude M; Scott CJM; Gao F; Lang AE; Breen DP; Tartaglia MC; Tan B; Swartz RH; Rogaeva E; Borrie M; Finger E; Fischer CE; Frank A; Freedman M; Kumar S; Pasternak S; Pollock BG; Rajji TK; Tang-Wai DF; Abrahao A; Turnbull J; Zinman L; Casaubon L; Dowlatshahi D; Hassan A; Mandzia J; Sahlas D; Saposnik G; Grimes D; Marras C; Steeves T; Masellis M; Farhan SMK; Bartha R; Symons S; Hegele RA; Black SE; Ramirez J;
    Alzheimers Dement; 2023 Dec; 19(12):5583-5595. PubMed ID: 37272523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of variants in HTRA1 and NOTCH3 with MRI-defined extremes of cerebral small vessel disease in older subjects.
    Mishra A; Chauhan G; Violleau MH; Vojinovic D; Jian X; Bis JC; Li S; Saba Y; Grenier-Boley B; Yang Q; Bartz TM; Hofer E; Soumaré A; Peng F; Duperron MG; Foglio M; Mosley TH; Schmidt R; Psaty BM; Launer LJ; Boerwinkle E; Zhu Y; Mazoyer B; Lathrop M; Bellenguez C; Van Duijn CM; Ikram MA; Schmidt H; Longstreth WT; Fornage M; Seshadri S; Joutel A; Tzourio C; Debette S
    Brain; 2019 Apr; 142(4):1009-1023. PubMed ID: 30859180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.
    Chung SJ; Lee YH; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2019 Sep; 66():105-109. PubMed ID: 31324555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal White Matter Damage Evolution in Parkinson's Disease.
    Scamarcia PG; Agosta F; Spinelli EG; Basaia S; Stojković T; Stankovic I; Sarasso E; Canu E; Markovic V; Petrović I; Stefanova E; Pagani E; Kostic VS; Filippi M
    Mov Disord; 2022 Feb; 37(2):315-324. PubMed ID: 34806799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease.
    Duering M; Csanadi E; Gesierich B; Jouvent E; Hervé D; Seiler S; Belaroussi B; Ropele S; Schmidt R; Chabriat H; Dichgans M
    Brain; 2013 Sep; 136(Pt 9):2717-26. PubMed ID: 23864274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal imaging analyses in patients with genetic and sporadic forms of small vessel disease.
    Kim KW; Kwon H; Kim YE; Yoon CW; Kim YJ; Kim YB; Lee JM; Yoon WT; Kim HJ; Lee JS; Jang YK; Kim Y; Jang H; Ki CS; Youn YC; Shin BS; Bang OY; Kim GM; Chung CS; Kim SJ; Na DL; Duering M; Cho H; Seo SW
    Sci Rep; 2019 Jan; 9(1):787. PubMed ID: 30692550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between white matter lesions and Parkinson's disease: an impact on Postural/Gait difficulty phenotype and cognitive performance.
    Sinani O; Dadouli K; Ntellas P; Kapsalaki EZ; Vlychou M; Raptis DG; Marogianni C; Markou K; Dardiotis E; Xiromerisiou G
    Neurol Res; 2022 Dec; 44(12):1122-1131. PubMed ID: 35994524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-Area Specific White Matter Hyperintensities: Associations to Falls in Parkinson's Disease.
    Ciliz M; Sartor J; Lindig T; Pilotto A; Schäffer E; Weiss M; Scheltens P; Becker S; Hobert MA; Berg D; Liepelt-Scarfone I; Maetzler W
    J Parkinsons Dis; 2018; 8(3):455-462. PubMed ID: 30040742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.